Leung Valerie, Gill Suzanne, Sauve Jaclyn, Walker Kelly, Stumpo Carmine, Powis Jeff
, BScPhm, ACPR, MBA, was, at the time this study was performed, the Clinical Manager with the Department of Pharmaceutical Services, Toronto East General Hospital, Toronto, Ontario. She is now a Clinical Leader with Canada Health Infoway.
Can J Hosp Pharm. 2011 Sep;64(5):314-20. doi: 10.4212/cjhp.v64i5.1065.
Promoting the appropriate use of antimicrobials is a core value of antimicrobial stewardship. Prospective audit and feedback constitute an effective strategy for reducing the cost and use of antimicrobials, as well as their adverse effects, such as infection with Clostridium difficile.
To evaluate the antimicrobial stewardship program in the intensive care unit at the authors' hospital, in order to determine the cost and utilization of antimicrobials, as well as the rate of nosocomially acquired C. difficile infection.
An infectious diseases team, consisting of a physician and a pharmacist, performed prospective audit and feedback during a pilot study (April to June 2010). The team met with the intensive care unit team daily to discuss optimization of therapy. The cost and utilization of antimicrobial drugs, as well as rates of C. difficile infection, were compared between the pilot period and the same period during the previous year (April to June 2009). For 3 months after the pilot phase (i.e., July to September 2010), the strategy was continued 3 days per week.
AFTER INTRODUCTION OF THE ANTIMICROBIAL STEWARDSHIP PROGRAM, THERE WAS A SIGNIFICANT REDUCTION IN THE COST OF ANTIMICROBIAL DRUGS: $27 917 less than during the same period in the previous year, equivalent to a reduction of $15.45 (36.2%) per patient-day ($42.63 versus $27.18). Utilization of broad-spectrum antipseudomonal antimicrobial agents was also significantly lower, declining from 63.16 to 38.59 defined daily doses (DDDs) per 100 patient-days (reduction of 38.9%). After the pilot period, the rate declined further, to 28.47 DDDs/100 patient-days. During the pilot period, there were no cases of C. difficile infection, and in the post-pilot period, there was 1 case (overall rate 0.42 cases/1000 patient-days). This rate was lower than (but not significantly different from) the rate for April to September 2009 (1.87 cases/1000 patient-days). There were no differences in mortality rate or severity of illness.
The antimicrobial stewardship program in this community hospital was associated with significant decreases in antimicrobial costs and in utilization of antipseudomonal antimicrobial agents and a nonsignificant decrease in the rate of C. difficile infection. Knowledge exchange, peer-to-peer communication, and decision support, key factors in this success, will be applied in implementing the antimicrobial stewardship program throughout the hospital.
促进抗菌药物的合理使用是抗菌药物管理的核心价值。前瞻性审核与反馈是降低抗菌药物成本及使用量及其不良影响(如艰难梭菌感染)的有效策略。
评估作者所在医院重症监护病房的抗菌药物管理项目,以确定抗菌药物的成本和使用情况,以及医院获得性艰难梭菌感染率。
一个由一名医生和一名药剂师组成的传染病团队在一项试点研究(2010年4月至6月)期间进行前瞻性审核与反馈。该团队每天与重症监护病房团队会面,讨论优化治疗方案。比较试点期间与上一年同期(2009年4月至6月)抗菌药物的成本和使用情况,以及艰难梭菌感染率。在试点阶段后的3个月(即2010年7月至9月),该策略每周持续3天。
引入抗菌药物管理项目后,抗菌药物成本显著降低:比上一年同期减少27917美元,相当于每位患者每天减少15.45美元(42.63美元对27.18美元),降幅为36.2%。广谱抗假单胞菌抗菌药物的使用量也显著降低,从每100个患者日63.16限定日剂量(DDD)降至38.59 DDD(降幅为38.9%)。试点期后,该使用率进一步降至28.47 DDD/100个患者日。在试点期间,没有艰难梭菌感染病例,在试点期后,有1例(总体发生率为0.42例/1000个患者日)。该发生率低于2009年4月至9月的发生率(1.87例/1000个患者日),但差异无统计学意义。死亡率和疾病严重程度无差异。
这家社区医院的抗菌药物管理项目与抗菌药物成本显著降低、抗假单胞菌抗菌药物使用量减少以及艰难梭菌感染率无显著降低有关。知识交流、同行沟通和决策支持是取得这一成功的关键因素,将应用于在全院实施抗菌药物管理项目。